Behold.ai has developed red dot®, an award-winning, artificially intelligent CT and X-Ray medical diagnosis platform. This innovative technology is capable of almost instantly detecting various conditions, including lung cancer and stroke, showcasing proven results both in the UK and globally. Notably, red dot® is FDA and CE approved, underscoring its reliability and effectiveness in the medical field. Behold.ai stands out as the only AI supplier regulated by the Care Quality Commission, highlighting its commitment to quality and safety in healthcare.
The platform leverages Behold’s AI-enabled autonomous diagnosis, powered by proprietary red dot® technology, to offer two core products designed to enhance medical diagnostics. These solutions have been recognized with awards, including the 'BEST DIGITAL HEALTH SOLUTION', a testament to their impact and innovation in digital health.
Behind Behold.ai is a team of experts led by Simon Rasalingham, Founder & CEO, along with Ruben Rasalingham, COO, Grainne Moynihan, CFO, and Dr. Tom Naunton-Morgan, Chief Medical Officer. Their collective expertise drives the company's mission to revolutionize medical diagnostics through AI.
Behold.ai's commitment to regulation and recognition is evident in its status as the only AI supplier regulated by the Care Quality Commission. This distinction not only sets Behold.ai apart in the healthcare technology sector but also reassures users of the platform's adherence to the highest standards of care and safety.
Located at WeWork, 123 Buckingham Palace Road, London, Behold.ai continues to lead in the development of AI solutions for medical diagnostics, offering tools that promise to transform the way healthcare professionals detect and manage diseases.
